Memorial Sloan Kettering (MSK) Cancer Center’s Senior Director of Clinical Research Informatics and Technology, Joe Lengfellner, tells us how MSK validated and scaled EHR-to-EDC technology across MSK’s vast portfolio of trials.
Editorial by Category
Modernizing Clinical Trial Operations
View All
Rethinking Study Startup with Novel Technology for Site-Sponsor Collaboration
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Site Networks Change Clinical Research Delivery and How Pharma Can Work Better With Them
Immuno-Oncology and Cell Therapy
View All
Going After Immune Resistance and Metastases in Cancer Using RNA-Based Therapeutics
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
GSK’s Head of Precision Medicine on Biomarker Focus and the Use of Next-Generation Technologies
T Cell Engagers, Moving Beyond Pembrolizumab, and Medicine Development for Future Patients, with Roche's Ashley Lakner
Drug Delivery
View All
Patients as Partners in Clinical Research and Patient Access
View All
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025
The Role of the Chief Medical Officer In Championing Patient-Centric Drug Development
Biotech CMO/R&D Leadership
View All
CRAACO: Clinical Research as a Care Option
View All
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Site Networks Change Clinical Research Delivery and How Pharma Can Work Better With Them
How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology
Women Leadership in Biotech
View All
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
